Skip to Content

Sodium Phosphate Injection

Last Updated: April 13, 2018
Status: Current

Sodium Phosphate Injection

Products Affected - Description
    • Sodium Phosphate injection, American Regent, 3 mmol/mL, 15 mL vial, 25 count, NDC 00517-3415-25
    • Sodium Phosphate injection, American Regent, 3 mmol/mL, 5 mL vial, 25 count, NDC 00517-3405-25
    • Sodium Phosphate injection, American Regent, 3 mmol/mL, 50 mL vial, 25 count, NDC 00517-3450-25
    • Sodium Phosphate injection, Pfizer, 3 mmol/mL, 15 mL vial, 25 count, NDC 00409-7391-72
Reason for the Shortage
    • American Regent has sodium phosphate injection on shortage due to manufacturing delay.[1]
    • Fresenius Kabi states the reason for the shortage is increased demand.[2]
    • Pfizer has sodium phosphate injection on shortage due to manufacturing delay.[3]
Available Products
    • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 15 mL vial, 25 count, NDC 63323-0170-15
    • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 5 mL vial, 25 count, NDC 63323-0170-05
    • Glycophos injection, Fresenius Kabi, 1 mmol/mL, 20 mL vial, 10 count, NDC 63323-0241-20

Estimated Resupply Dates

    • American Regent has sodium phosphate 3 mmol/mL 5 mL, 15 mL, and 50 mL vials on back order and the company cannot estimate a release date.[1]
    • Pfizer has sodium phosphate 3 mmol/mL 15 mL vials on back order and the company estimates a release date of March 2019.[3]

Implications for Patient Care

    • Phosphate injection products are used to treat and prevent hypophosphatemia.[4]

Alternative Agents & Management

    • In cooperation with FDA, Fresenius Kabi USA is providing Glycophos (sodium glycerophosphate) injection to the US market to help alleviate the shortage of phosphate injections. Glycophos is manufactured in an FDA-approved facility in Norway by Fresenius Kabi AG. Details can be found on https://www.fda.gov/downloads/drugs/drugsafety/drugshortages/ucm591758.pdf

References

    1. American Regent Laboratories (personal communications and website). March 10 and 30, April 27, May 24, June 22, July 27, August 25, September 27, October 31, November 22, December 19, 2016; January 20, March 6, April 3, May 8, July 6 and 25, September 6 and 18, December 8 and 20, 2017; January 29, and February 23, 2018.
    2. Fresenius Kabi (personal communications). March 10 and 30, April 22, May 23, June 20, July 22, August 18, September 23, October 27, November 21, December 19, 2016; January 20, March 5, April 3 and 28, June 8, July 6 and 19, August 31, September 15, October 4, November 30, December 22, 2017; January 10 and 26, February 15, and April 13, 2018.
    3. Pfizer (personal communications and website). March 10 and 30, April 27, May 24, June 23, July 27, August 25, September 27, October 31, December 19, 2016; January 20, March 8, April 3, May 5, June 9, July 6 and 25, September 1 and 15, October 6, December 8 and 29, 2017; January 8 and 26, February 23, and April 13, 2018.
    4. Lexi-Drugs Online. Hudson, OH: Lexi-Comp, Inc.; 2016.

Updated

Updated April 13, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 10, 2016 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide